Lilly vs. Pfizer: Acquisition spree comparison
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. GLP-1 revenue at Eli Lilly and Novo Nordisk, 2022-2025. Lilly’s tirzepatide franchise grew more than fivefold…
Posted inAI
The 40 Best Free AI Tools in 2026
Discover the best free AI tools of 2026. Explore top-rated free AI video generation tools, free AI image generation tools, coding assistants, and more. Subscription fatigue is real. Between streaming…
Posted inBiologic Drugs BioTech Medicines
mAB production:: Series Wrap‑Up – The Complete Manufacturing Journey of a Monoclonal Antibody
From a single gene in a plasmid to a vial in the patient’s hand: reflections on the 11 steps that make biologic medicines possible. Over the past weeks, we have…
Posted inBiologic Drugs BioTech Medicines
mAB production: Step 11 – Sterile Filling and Finishing: From Bulk Drug Substance to Patient‑Ready Vial
How we sterile‑filter, fill, inspect, label, and package the monoclonal antibody under aseptic conditions. Welcome back to our deep‑dive series on monoclonal antibody manufacturing. In Step 10, we performed ultrafiltration…
Posted inBiologic Drugs BioTech Medicines
mAB production: Step 10 – Ultrafiltration and Diafiltration (UF/DF): Concentration and Formulation
How we concentrate the monoclonal antibody to its final strength and exchange the buffer into the stable, injectable formulation. Welcome back to our deep‑dive series on monoclonal antibody manufacturing. In…
Posted inBiologic Drugs BioTech Medicines
mAB production: Step 9 – Viral Filtration (Nanofiltration): The Physical Barrier for Virus Safety
How we use size‑exclusion membranes with 20 nm pores to retain viruses while allowing the monoclonal antibody to pass. Welcome back to our deep‑dive series on monoclonal antibody manufacturing. In…
Posted inBiologic Drugs BioTech Medicines
mAB production: Step 8 – Anion Exchange Chromatography: Flow‑Through Polishing for DNA and Endotoxin Removal
How we use a negatively charged resin to let the mAb flow through while binding trace impurities that could compromise patient safety. Welcome back to our deep‑dive series on monoclonal…
Posted inBiologic Drugs BioTech Medicines
mAB production: Step 7 – Cation Exchange Chromatography: The First Polishing Step
How we use electrostatic interactions to remove aggregates, leached Protein A, HCPs, and DNA after viral inactivation. Welcome back to our deep‑dive series on monoclonal antibody manufacturing. In Step 6,…
Posted inBiologic Drugs BioTech Medicines
Lilly investing billions to prepare for overseas oral GLP-1 launches
With many overseas patients preferring orals to injectables, Eli Lilly has filed for approval of orforglipron in more than 40 countries and is building manufacturing capacity to support the obesity…
Posted inBiologic Drugs BioTech Medicines
mAB production: Step 6 – Low pH Viral Inactivation: A Regulatory Imperative
How we exploit the low pH elution condition from Protein A chromatography to inactivate enveloped viruses while protecting the antibody. Welcome back to our deep‑dive series on monoclonal antibody manufacturing.…